Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 20.71 M40.08 M — Research & development —— — Operating income 86.64 M70.04 M — Non-Operating Income, Total -24.73 M-24.52 M — Interest expense, net of interest capitalized 25.82 M26.47 M — Non-Operating Income, excl. Interest Expenses -50.56 M-50.99 M — Unusual income/expense —— — Pretax income 61.91 M45.51 M — Equity in earnings —— — Taxes 14.26 M7.15 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 47.65 M38.36 M — Discontinued operations —— — Net income 47.65 M38.36 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 47.65 M34.56 M — Basic earnings per share (Basic EPS) 18.610.59 — Diluted earnings per share (Diluted EPS) 16.760.59 — Average basic shares outstanding 1.29 M20.49 M — Diluted shares outstanding 1.43 M20.49 M — EBITDA 88.02 M71.56 M — EBIT 86.64 M70.04 M — Cost of revenue 560 K569 K — Other cost of goods sold —— — Depreciation & amortization (cash flow) 1.37 M1.52 M —